Millennium Management’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Millennium Management’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,981	Closed	-$84K	–	7731
2021 Q4	$84K	Sell	1,981 -5,978	-75%	-$373K	﹤0.01%	6321
2021 Q3	$540K	Buy	7,959 +7,735	+3,453%	+$566K	﹤0.01%	5278
2021 Q2	$17K	Sell	224 -5,698	-96%	-$347K	﹤0.01%	6437
2021 Q1	$390K	Buy	+5,922	New	+$461K	﹤0.01%	5027
2020 Q4	–	Sell	-286	Closed	-$16K	–	5696
2020 Q3	$16K	Sell	286 -580	-67%	-$34.4K	﹤0.01%	4358
2020 Q2	$33K	Buy	866 +91	+12%	+$3.11K	﹤0.01%	4074
2020 Q1	$19K	Buy	+775	New	+$32.9K	﹤0.01%	3737
2019 Q4	–	Sell	-398	Closed	-$19K	–	4729
2019 Q3	$19K	Buy	+398	New	+$28.6K	﹤0.01%	4090
2019 Q2	–	Sell	-1,316	Closed	-$194K	–	4586
2019 Q1	$194K	Buy	+1,316	New	+$254K	﹤0.01%	3748
2018 Q2	–	Sell	-616	Closed	-$151K	–	4281
2018 Q1	$151K	Hold	616	–	–	﹤0.01%	3427
2017 Q4	$190K	Buy	616 +200	+48%	+$65.8K	﹤0.01%	3546
2017 Q3	$152K	Buy	416 +250	+151%	+$88.7K	﹤0.01%	3311
2017 Q2	$61K	Buy	+166	New	+$49.7K	﹤0.01%	3353
2016 Q4	–	Sell	-347	Closed	-$83K	–	3838
2016 Q3	$83K	Buy	+347	New	+$72.1K	﹤0.01%	3152

Other funds holding DMK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Millennium Management's DMK Position: Q1 2022 in Review

Millennium Management sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2022, closing a stake of 1,981 shares — an estimated $84K sold.

Millennium Management first reported a position in DMK in Q3 2016 and held it in 14 quarters. The position peaked at $540K in Q3 2021. 46 funds tracked by Wall St. Rank hold DMK as of Q1 2022.

Millennium Management reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2022 after selling out during the quarter.
Millennium Management sold 1,981 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2022, an estimated $84K.
Millennium Management first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q3 2016 and held it in 14 quarters.
Millennium Management's DMK Pharmaceuticals Corporation Common Stock position peaked at $540K in Q3 2021.
46 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2022.

Based on Millennium Management's 13F filing for Q1 2022, filed 16 May 2022.